ORIGIMM Biotechnology GmbH
www.origimm.comSANOFI and Origimm have joined forces to expand and accelerate the development of a vaccine candidate to prevent and treat acne vulgaris. https://www.sanofi.com/en/media-room/press-releases/2021/2021-12-01-07-00-00-2343720
Read more
SANOFI and Origimm have joined forces to expand and accelerate the development of a vaccine candidate to prevent and treat acne vulgaris. https://www.sanofi.com/en/media-room/press-releases/2021/2021-12-01-07-00-00-2343720
Read more
Country
City (Headquarters)
Vienna
Industry
Employees
11-50
Founded
2012
Estimated Revenue
$1 to $1,000,000
Social
Employees statistics
View all employeesPotential Decision Makers
Chief Executive Officer and Chief Security Officer ( Founder )
Email ****** @****.comPhone (***) ****-****Head of Quality
Email ****** @****.comPhone (***) ****-****Head of Business Development
Email ****** @****.comPhone (***) ****-****Executive Assistant to Chief Executive Officer , Organizational and Team Development
Email ****** @****.comPhone (***) ****-****
Technologies
(14)
Reach decision makers at ORIGIMM Biotechnology GmbH
Free credits every month!
ORIGIMM Biotechnology GmbH FAQ
Vienna, Austria
Biotechnology Research
We'll help you understand if Lusha can solve your business needs.
